855. The Role of the CLSI in Establishing and Revising Breakpoints
Session: Symposium: Susceptibility Breakpoints Controversies and Consensus
Saturday, October 23, 2010: 11:00 AM
Parkview Terrace / 1-3

James H. Jorgensen, PhD , The University of Texas Health Science Center San Antonio, San Antonio, TX


J. H. Jorgensen, Yes
Becton Dickinson: Investigator and Scientific Advisor, Consulting fee and Research support
bioMerieux: Investigator, Research support
Merck: Grant Investigator, Research grant
Pfizer: Grant Investigator, Research grant
Rib-X Pharmaceuticals: Consultant, Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.


Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org